Instrument Inactif

Communiqués CORIUM Nasdaq

Actions

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

27/01/20	Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease	GL
02/04/19	Corium Appoints Perry Sternberg as Chief Executive Officer	GL
17/12/18	Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025	GL
15/10/18	Corium International : RM LAW Announces Investigation of Corium International, Inc.	PR
12/10/18	CORIUM INTERNATIONAL, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
12/10/18	Corium (CORI) Alert: Johnson Fistel Investigates Proposed Sale of Corium International, Inc. to Gurnet Point Capital; Are Shareholders Getting a Fair Deal?	PR
11/10/18	Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares	GL
24/09/18	Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference	GL
29/08/18	Corium to Present at the H. C. Wainwright 20th Annual Global Investment Conference	GL
09/08/18	Corium Reports Third Quarter Fiscal 2018 Financial Results and Corporate Highlights	GL
02/08/18	Corium to Report Third Quarter Fiscal 2018 Financial Results on Thursday, August 9, 2018	GL
24/05/18	Corium to Present at the Jefferies 2018 Global Healthcare Conference	GL
14/05/18	Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights	GL
01/03/18	Corium Prices Offering of $100 Million of 5% Convertible Senior Notes	GL
28/02/18	Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study	GL
08/02/18	Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights	GL
06/02/18	Corium to Present at Upcoming Healthcare Investor Conferences	GL
01/02/18	Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018	GL
16/11/17	Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights	GL
09/11/17	Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017	GL
05/09/17	Corium to Present at Upcoming Healthcare Conferences	GL
03/08/17	Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017	GL
27/07/17	Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017	GL
18/07/17	Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex™ Donepezil Transdermal System at Alzheimer's Association International Conference® 2017	GL
06/07/17	Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex™ Donepezil Transdermal System at Alzheimer's Association International Conference® 2017	GL